Results 121 to 130 of about 2,530,443 (206)

Prostate Cancer Development, Progression, and Therapy

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin   +9 more
wiley   +1 more source

PMS2 and its role in mismatch repair deficiency syndrome

open access: yes, 2011
The PMS2 protein IS a component of the post-replicative DNA mismatch repair (MMR) system, which acts to correct mispaired nucleotides and small insertion-deletion loops in new DNA duplexes.
Ingham, Danielle
core  

Dye tags influence single expression of MLH1 and PMS2.

open access: yes, 2013
To determine the influence of fluorescent tags on single expressed MLH1 or PMS2 variants, HEK293T cells were transfected with different (A) MLH1 or (B) PMS2 constructs.
Ronja Adam (333161)   +5 more
core   +1 more source

The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics

open access: yesClinical Genetics, Volume 110, Issue 3, Page 389-401, September 2026.
The WHO Classification of Tumours underpins the diagnosis of neoplastic conditions. The new WHO classification of genetic tumour syndromes (GTS) provides international standards for their diagnosis. This diagram highlights the chromosomal distribution of the genes involved in the GTS covered in this classification.
Ian A. Cree   +18 more
wiley   +1 more source

Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort

open access: yesHistopathology, Volume 89, Issue 3, Page 442-455, September 2026.
GBASCs are MMRp tumours, exhibiting minimal HER2 overexpression and elevated PD‐L1 expression compared to adenocarcinomas. Especially in metastatic and TP53‐wild type tumours, GBASCs can express CLDN18, albeit limited to the glandular component. Their genomic profile resembles that of adenocarcinomas with an enrichment in alterations on PIK3CA, PTEN ...
Jessica Gasparello   +20 more
wiley   +1 more source

Defect in the apoptotic response to cisplatin caused by the R20Q variant of the PMS2 protein

open access: yes, 2008
Popravljači pogrešno sparenih baza (MMR) obavljaju popravak replikacijskih pogrešaka nastalih tijekom DNA sinteze. Isto tako, MMR proteini kod sisavaca imaju sposobnost aktivacije kontrolne točke staničnog ciklusa, te pokretanja apoptoze kao odgovora na ...
Marinović Terzić, Ivana
core   +3 more sources

Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis

open access: yesCancer Medicine
Background While previous studies have indicated variability in distant metastatic potential among different mismatch repair (MMR) states in colorectal cancer (CRC), their findings remain inconclusive, especially considering potential differences across ...
Chuanwen Fan   +11 more
doaj   +1 more source

PMS2 Gene Expression Analysis in Blood of Postmenopausal Women with Breast Cancer: A Comparative Study

open access: yesSaudi Journal of Medicine
Background/aim: The PMS2 gene was evaluated for its role in the pathogenesis of breast cancer by analyzing its expression in blood samples obtained from healthy postmenopausal women, newly diagnosed breast cancer patients, and the same patients following surgical and therapeutic treatment.
Asma Asma   +2 more
openaire   +1 more source

Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers

open access: yesDiagnostics
The immunohistochemical assessment of mismatch repair (MMR) proteins represents a pivotal screening tool for identifying Lynch syndrome (LS)-related cancers, as the loss of their expression often indicates MMR dysfunction associated with genetic or ...
Gianmaria Miolo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy